Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
about
Vasopressin and metabolic disorders: translation from experimental models to clinical use.The vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans.Copeptin reflects physiological strain during thermal stress.Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank.Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
P2860
Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Plasma Copeptin, Kidney Outcom ...... Long-standing Type 1 Diabetes.
@en
Plasma Copeptin, Kidney Outcom ...... Long-standing Type 1 Diabetes.
@nl
type
label
Plasma Copeptin, Kidney Outcom ...... Long-standing Type 1 Diabetes.
@en
Plasma Copeptin, Kidney Outcom ...... Long-standing Type 1 Diabetes.
@nl
prefLabel
Plasma Copeptin, Kidney Outcom ...... Long-standing Type 1 Diabetes.
@en
Plasma Copeptin, Kidney Outcom ...... Long-standing Type 1 Diabetes.
@nl
P2093
P50
P356
P1433
P1476
Plasma Copeptin, Kidney Outcom ...... Long-standing Type 1 Diabetes.
@en
P2093
Guillaume Lefèvre
Kamel Mohammedi
Louis Potier
Michel Marre
Nadine Bouby
Ray El Boustany
Ronan Roussel
Samy Hadjadj
P304
P356
10.2337/DC16-1003
P407
P577
2016-10-11T00:00:00Z